Keyword: Cerevel Therapeutics
Robertson, M.D., who led global development teams within Shire’s neuroscience division, is now Yumanity Therapeutics’ chief medical officer.
Bayer dumps two execs in corporate reshuffle; Coles to take over at Bayer spinoff Cerevel; Sanofi vet Jensen wins CMO spot at Vifor.
The appointment puts the man who led Onyx to a $10 billion takeover in charge of a pipeline of neuroscience programs.
Pfizer spun off some of its CNS assets into Cerevel Therapeutics in 2018.